Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation

Esta versión no es la más reciente

ver la versión actual 02 diciembre 2013

Información

DOI:
https://doi.org/10.1002/14651858.CD006573.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 08 diciembre 2010see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Hepatobiliar

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Kurinchi Selvan Gurusamy

    Correspondencia a: Department of Surgery, Royal Free Campus, UCL Medical School, London, UK

    [email protected]

  • Emmanuel Tsochatzis

    The Royal Free Sheila Sherlock Liver Centre and Division of Surgery, Royal Free Hospital, London, UK

  • Brian R Davidson

    University Department of Surgery, Royal Free Hospital and University College School of Medicine, London, UK

  • Andrew K Burroughs

    Liver Transplantation and Hepatobiliary Medicine, Royal Free Hospital, London, UK

Contributions of authors

KS Gurusamy wrote the review, assessed the trials for inclusion, and extracted data on included trials. E Tsochatzis extracted the data on included trials. AK Burroughs and BR Davidson critically commented on the review and provided advice for improving the review.

Sources of support

Internal sources

  • none, Not specified.

External sources

  • Hellenic Association for the Study of the Liver, Greece.

    Dr E Tsochatzis receives an educational grant for his research in United Kingdom

Declarations of interest

None known.

Acknowledgements

To Martyn Parker, author of more than 15 Cochrane reviews, who inspired the first author to write Cochrane reviews.
To The Cochrane Hepato‐Biliary Group for the support that they have provided.

Peer Reviewers: Tullia Maria De Feo, Italy.
Contact Editor: Ronald Koretz, USA.

Version history

Published

Title

Stage

Authors

Version

2013 Dec 02

Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation

Review

Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Clare D Toon, Brian R Davidson, Andrew K Burroughs

https://doi.org/10.1002/14651858.CD006573.pub3

2010 Dec 08

Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation

Review

Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Brian R Davidson, Andrew K Burroughs

https://doi.org/10.1002/14651858.CD006573.pub2

2007 Jul 18

Antiviral prophylactic intervention for hepatitis C virus in patients undergoing liver transplantation

Protocol

Kurinchi Selvan Gurusamy, Kumarakrishnan Samraj, Brian R Davidson

https://doi.org/10.1002/14651858.CD006573

Differences between protocol and review

The outcomes have been divided into primary and secondary outcomes and ordered by clinical importance. The re‐transplantation and graft rejection outcomes have now been defined clearer, ie, as those occurring after the start of therapy. Liver decompensation has been added to the primary outcomes, as this is an important clinical outcome that can be influenced by treatment. The methods of assessing the risk of bias in the different trials have been revised according to the updated version of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2009). Methods for obtaining information on hazard ratio have been clearly stated.